Trump Administration Wants to Protect FDA Power Over Abortion Pill
What: DOJ seeks dismissal of red-state lawsuit—not to defend the pill, but to preserve federal authority.
Key Line: “‘They’re basically saying states don’t get to just challenge FDA policy because they want to.’”
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Yale study shows women in Southern states barely gained life expectancy over 100 years.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Systemic hormones may worsen incontinence; local therapy helps, study says.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
A major study ties maternal diabetes to neurodevelopmental issues in children.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
A former NIH director calls for institutional changes to better prioritize female health.
A former NIH director calls for institutional changes to better prioritize female health.
NIH, NSF, and women’s health research all targeted in proposed budget.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
Syphilis cases surged 80%; treatment gaps tied to stillbirth and NICU stays.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
A small increase in births among women in their 30s and 40s offsets younger declines.
Trump promotes IVF access while cutting the team responsible for tracking it.